# Phase 3 arthritis trials recruiting: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 3 for arthritis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 arthritis trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/arthritis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 13, 2026 | NCT07871721 | A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) | Takeda | Phase 3 | Not yet recruiting | Psoriatic Arthritis | 644 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871721) |
| September 2, 2026 | NCT07800351 | Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis | Tanta University | Phase 3 | Not yet recruiting | Rheumatoid Arthritis (RA, Atherosclerosis | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800351) |
| August 27, 2026 | NCT07791199 | Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers | Bristol-Myers Squibb | Phase 3 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Psoriasis, Psoriatic Arthritis | 2,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07791199) |
| June 4, 2026 | NCT07625384 | Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease | R-Pharm International, LLC | Phase 3 | Not yet recruiting | Still Disease | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625384) |
| May 12, 2026 | NCT07580976 | Tru-Vu Wrist Positioning Aid Multi-Center Implementation Within NLHS | Western University | Phase 3 | Not yet recruiting | Trauma (Including Fractures), Arthritis | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580976) |
| April 28, 2026 | NCT07554495 | Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis... | Alfasigma S.p.A. | Phase 3 | Recruiting | Polyarticular Course Juvenile Idiopathic Arthritis | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554495) |
| April 27, 2026 | NCT07553182 | OLE Study With Filgotinib in JIA | Alfasigma S.p.A. | Phase 3 | Recruiting | Juvenile Idiopathic Arthritis (JIA) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553182) |
| December 16, 2025 | NCT07286058 | Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis | Takeda | Phase 3 | Recruiting | Psoriatic Arthritis | 1,182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07286058) |
| May 11, 2025 | NCT06966206 | Multiprofen-CC to Reduce Pain in Hand Arthritis | St. Joseph's Healthcare Hamilton | Phase 3 | Recruiting | Hand Osteoarthritis | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06966206) |
| March 11, 2025 | NCT06869551 | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic... | Bristol-Myers Squibb | Phase 3 | Recruiting | Juvenile Psoriatic Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06869551) |
| March 7, 2025 | NCT06863701 | Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis | Laboratorios Silanes S.A. de C.V. | Phase 3 | Recruiting | Gout Arthritis, Gout Attack | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06863701) |
| October 31, 2024 | NCT06668181 | An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile... | UCB Biopharma SRL | Phase 3 | Recruiting | Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06668181) |
| October 29, 2024 | NCT06663332 | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06663332) |
| October 23, 2024 | NCT06654882 | Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis | Duke University | Phase 3 | Recruiting | Polyarticular Course Juvenile Idiopathic Arthritis (JIA) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06654882) |
| October 25, 2023 | NCT06100744 | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic... | AbbVie | Phase 3 | Recruiting | Juvenile Psoriatic Arthritis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06100744) |
| March 14, 2023 | NCT05767047 | A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis | Amgen | Phase 3 | Recruiting | Behçet's Disease, Juvenile Psoriatic Arthritis | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05767047) |
| March 6, 2023 | NCT05756179 | Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis | Alexandria University | Phase 3 | Recruiting | Rheumatoid Arthritis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05756179) |
| November 8, 2022 | NCT05609630 | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug... | AbbVie | Phase 3 | Recruiting | Juvenile Idiopathic Arthritis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05609630) |
| June 23, 2022 | NCT05428488 | Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis | University Hospital, Montpellier | Phase 3 | Recruiting | Rheumatoid Arthritis | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05428488) |
| October 26, 2021 | NCT05092984 | Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA) | University Hospital, Strasbourg, France | Phase 3 | Recruiting | Rheumatoid Arthritis | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05092984) |
| March 18, 2021 | NCT04804553 | Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | Amgen | Phase 3 | Recruiting | Active Juvenile Psoriatic Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04804553) |
| December 31, 2020 | NCT04692493 | RA-PRO PRAGMATIC TRIAL | University of Alabama at Birmingham | Phase 3 | Recruiting | Rheumatoid Arthritis | 924 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04692493) |
| December 12, 2018 | NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis | Eli Lilly and Company | Phase 3 | Recruiting | Juvenile Idiopathic Arthritis | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03773965) |
| December 10, 2018 | NCT03770923 | Effect of Some Drugs on Rheumatoid Arithritis Activity | Sponsor not shown (see the record) | Phase 3 | Recruiting | Rheumatoid Arthritis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03770923) |
| December 10, 2018 | NCT03770702 | Statins and ARBs on Rheumatoid Activity | Sponsor not shown (see the record) | Phase 3 | Recruiting | Rheumatoid Arthritis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03770702) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 2 |
| [Alfasigma S.p.A.](https://specstream.ai/data/clinical-trials/company/alfasigma-s-p-a) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| Alexandria University | 1 |
| St. Joseph's Healthcare Hamilton | 1 |
| Western University | 1 |
| University Hospital, Strasbourg, France | 1 |
| Tanta University | 1 |
| University of Nebraska | 1 |
| University of Alabama at Birmingham | 1 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 1 |
| University Hospital, Montpellier | 1 |
| R-Pharm International, LLC | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| [Laboratorios Silanes S.A. de C.V.](https://specstream.ai/data/clinical-trials/company/laboratorios-silanes-s-a-de-c-v) | 1 |
| [UCB Biopharma SRL](https://specstream.ai/data/clinical-trials/company/ucb-biopharma-srl) | 1 |
| Duke University | 1 |

## By country

| Country | Trials |
| --- | --- |
| Germany | 11 |
| Spain | 10 |
| Italy | 9 |
| United Kingdom | 9 |
| France | 9 |
| United States | 8 |
| Poland | 7 |
| Turkey (Türkiye) | 6 |
| Australia | 5 |
| China | 5 |
| Canada | 5 |
| Egypt | 4 |
| Argentina | 4 |
| Czechia | 4 |
| Israel | 4 |
| Japan | 4 |
| Belgium | 4 |
| Brazil | 4 |
| Hungary | 3 |
| Netherlands | 3 |
| Mexico | 3 |
| Puerto Rico | 2 |
| Taiwan | 2 |
| Greece | 2 |
| Portugal | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dim sum restaurants in the United States](https://specstream.ai/data/businesses/dim-sum-restaurants/united-states)
- [Business schools in the United States](https://specstream.ai/data/businesses/business-schools/united-states)
- [AV equipment rental companies in the United States](https://specstream.ai/data/businesses/av-equipment-rental-companies/united-states)
- [Vehicle parts manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-parts-manufacturers/united-states)
- [Social media agencies in the United States](https://specstream.ai/data/businesses/social-media-agencies/united-states)
- [Pool and hot tub services in the United States](https://specstream.ai/data/businesses/pool-and-hot-tub-services/united-states)
